• 한국자원식물학회지
• /
• 제28권4호
• /
• pp.411-418
• /
• 2015

Lonicera caerulea var. edulis is a rare species found in some alpine region of Korea. Genetic variation in L. caerulea var. edulis has been investigated by examining 161 individuals from six natural populations: Mt. Seorak 1, Mt. Seorak 2, Mt. Jeombong, Mt. Bangtae, Mt. Gyebang, Mt. Halla. The mean genetic diversity for all the six populations was 0.25 (S.I.). The highest genetic diversity was found in Mt. Seorak (S.I.=0.3158) and the lowest was in Mt. Gyebang (S.I.=0.1047). Comparatively low level of genetic diversity was observed (Ae=1.25, P= 64.6%, S.I.=0.25), which is a typical pattern for rare tree species. AMOVA showed exceptionally large proportion of genetic variations both for among populations (34.69%) and within populations (65.31%). Excluding Mt. Gyebang, the genetic variation among and within population was 18.71% and 81.29% respectively. The UPGMA dendrogram based on genetic distance is not suitable for geographic relationship. Genetic distance of Mt. Gyebang was most distant from the other populations. Excluding Mt. Gyebang, the genetic identities among the five populations were 0.95 to 0.97, which is very high similarity level of genetic identity. This low level of genetic variations and the lack of site in nature indicates that Lonicera caerulea var. edulis demanded a serious conservation.

• 한국환경생태학회지
• /
• 제35권1호
• /
• pp.37-47
• /
• 2021

본 연구에서는 최근 가속화되고 있는 기후변화로 인하여 쇠퇴가 우려되는 설악산 분비나무림을 대상으로 식물사회학적 연구를 수행하였다. 현장조사에서 획득된 70개 방형구 조사결과에 대해 TWINSPAN 기법을 이용하여 군락을 분류하고, DCA 방법으로 서열을 분석한 후 각 군락이 갖는 특성을 분석하였다. 설악산 분비나무림은 4개 군락(분비나무-댕댕이나무군락, 분비나무-시닥나무군락, 분비나무-당단풍나무군락, 분비나무-거제수나무군락)으로 구분되었다. 각 군락은 입지에 따라 분포 유형을 달리하였으며, 이는 해발고도, 사면 등 입지환경에 따라 서로 다른 미소환경이 형성됨으로써 종조성이 달리지기 때문이다. 각 군락은 분포 고도, 암석비율, 토양특성, 낙엽층 두께 등의 환경에서 차이를 보였으며, 그 결과로 종구성의 차이뿐만 아니라 출현종수 및 개체수, 식피율, 수목규격, 종다양도 등에서 군락 간 유의미한 차이를 보였다. 분비나무-댕댕이나무군락과 분비나무-시닥나무군락은 높은 고도의 암석비율이 높은 곳에 입지하며 교목층 발달이 미약하였다. 반면, 분비나무-당단풍나무군락과 분비나무-거제수나무군락은 분포 고도가 상대적으로 낮고 토양비율이 높았으며, 교목층이 발달하고 종다양도가 높게 나타났다.

• Nutrition Research and Practice
• /
• 제13권5호
• /
• pp.367-376
• /
• 2019

BACKGROUND/OBJECTIVE: The blue honeysuckle berry (Lonicera caerulea var. edulis L.) is a small deciduous shrub belonging to the Caprifoliaceae family that is native to Russia, China, Japan, and Korea. The berry of this shrub is edible, sweet and juicy and is commonly known as the blue honeyberry (BHB). This study examined the anti-diabetic potential of BHB on high-fat-diet-induced mild diabetic mice. The hypoglycemic, and nephroprotective effects of the 12-week oral administration of blue honeyberry extract were analyzed. MATERIALS/METHODS: The hypoglycemic effects were based on the observed changes in insulin, blood glucose, and glycated hemoglobin (HbA1c). Furthermore, the changes in the weight of the pancreas, including its histopathology and immunohistochemical investigation were also performed. Moreover, the nephroprotective effects were analyzed by observing the changes in kidney weight, its histopathology, blood urea nitrogen (BUN), and serum creatinine levels. RESULTS: The results showed that the high-fat diet (HFD)-induced control mice showed a noticeable increase in blood glucose, insulin, HbA1c, BUN, and creatinine levels. Furthermore, growth was observed in lipid droplet deposition related to the degenerative lesions in the vacuolated renal tubules with the evident enlargement and hyperplasia of the pancreatic islets. In addition, in the endocrine pancreas, there was an increase in the insulin-and glucagon-producing cells, as well as in the insulin/glucagon cell ratios. On the other hand, compared to the HFD-treated mice group, all these diabetic and related complications were ameliorated significantly in a dose-dependent manner after 84 days of the continuous oral administration of BHBe at 400, 200 and 100 mg/kg, and a dramatic resettlement in the hepatic glucose-regulating enzyme activities was observed. CONCLUSIONS: By assessing the key parameters for T2DM, the present study showed that the BHBe could act as a potential herbal agent to cure diabetes (type II) and associated ailments in HFD-induced mice.